Clinical characteristics of hereditary hemorrhagic telangiectasia – case series and review of the literature

  • Dragan Popović University of Belgrade, Faculty of Medicine, Belgrade, Serbia; Clinical Centre of Serbia
  • Aleksandrac Sokić-Milutinović University of Belgrade, Faculty of Medicine, Belgrade, Serbia; Clinical Centre of Serbia
  • Srđan Djuranović University of Belgrade, Faculty of Medicine, Belgrade, Serbia; Clinical Centre of Serbia
  • Tamara Alempijević University of Belgrade, Faculty of Medicine, Belgrade, Serbia; Clinical Centre of Serbia
  • Sanja Zgradić Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
  • Vera Matović Clinical Centre of Serbia, Emergency Center, Belgrade, Serbia
  • Ljubiša Tončev Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
  • Snežana Lukić University of Belgrade, Faculty of Medicine, Belgrade, Serbia
Keywords: telangiectasia, herediatary hemorrhagic;, diagnosis, differential;, hemoptysis;, digestive system;, hemorrhage;, arteriovenous malformation.

Abstract


Introduction. Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder with esti­mated prevalence of one in 5,000 to 10,000. The disease has age-related penetrance and the HHT signs and symptoms occur and worsen with age. A diagnosis of HHT is based on the Curacao`s criteria. Case report. We report a case series of 6 patients diagnosed with HHT, 5 with definite and one with probable diagnosis according to the Curacao criteria. In 5 patients, the recurrent epistaxis occurred in adolescence as the first presentation while one patient presented with melena. The diagnosis was delayed in 5 patients and the presence of HHT was diagnosed during or after the fifth decade. In 4 patients, the overt gastrointestinal bleeding oc­curred in the later course of the disease. The asymptomatic pulmonary circulation arteriovenous malformations were detected in 2 patients. The cerebral arteriovenous malfor­mations were not detected. Conclusion. Hereditary hemor­rhagic telangiectasia is a rare disorder affecting multiple or­gans. It should be considered in the adolescents with recur­rent epistaxis and in the differential diagnosis of anemia with signs of the gastrointestinal bleeding in order to shorten the delay in the diagnosis and subsequently improve the outcome of the disease.

References

Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med 2014; 5: 191‒206.

Pierucci P, Lenato GM, Suppressa P, Lastella P, Triggiani V, Valerio R, et al. A long diagnostic delay in patients with he-reditary haemorrhagic telangiectasia: A questionnaire-based retrospective study. Orphanet J Rare Dis 2012; 7: 33.

Grand`Maison A. Hereditary hemorrhagic telangiectasia. CMAJ 2009; 180(8): 833–5.

Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91(1): 66–7.

Ni Bhuachalla CF, O' Connor TM, Murphy M, Colwell N, Brady A. Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003–2008. Respir Med 2010; 104(8): 1218‒24.

Dheyauldeen S, Abdelnoor M, Bachmann-Harildstad G. The natu-ral history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study. Am J Rhinol Allergy 2011; 25(4): 214‒8.

Porteus ME, Burn J, Procter SJ. Hereditary hemorrhagic telangi-ectasia: a clinical analysis. J Med Genet 1992; 29(8): 527–30.

Longacre AV, Gross CP, Gallitelli M, Henderson KJ, White RI Jr, Proctor DD. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiecta-sia. Am J Gastroenterol 2003; 98(1): 59‒65.

Shovlin CL. Hereditary haemorrhagic telangiectasia: patho-physiology, diagnosis and treatment. Blood Rev 2010; 24(6): 203–19.

van Gent MW, Post MC, Snijder RJ, Westermann CJ, Plokker HW, Mager JJ. Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hem-orrhagic telangiectasia: a transthoracic contrast echocardiog-raphy study. Chest 2010; 138: 833‒9.

Khurshid I, Downie GH. Pulmonary arteriovenous malfor-mations. Postgrad Med J 2002; 78(918): 191‒7.

te Veldhuis EC, te Veldhuis AH, van Dijk FS, Kwee ML, van Ha-gen JM, Baart JA, et al. Rendu-Osler-Weber disease: update of medical and dental considerations. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2008; 105(2): e38–e41.

Woodall MN, McGettigan M, Figueroa R, Gossage JR, Alleyne CH Jr. Cerebral vascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2014; 120(1): 87‒92.

Yang W, Liu A, Hung A, Braileanu M, Wang JY, Caplan JM, et al. Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telan-giectasia. Neurosurgery 2016; 78(5): 684‒93.

Published
2021/02/10
Section
Original Paper